Docetaxel in Treating Patients With Solid Tumors and Abnormal Liver Function
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die.
PURPOSE: Phase I trial to study the effectiveness of docetaxel in treating patients with
advanced solid tumors that have not responded to standard therapy or for which there is no
effective therapy.